🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 13/06/2011 | 0,3626 USD |
| 11/03/2011 | 0,3626 USD |
| 13/12/2010 | 0,3626 USD |
| 13/09/2010 | 0,3626 USD |
| 11/06/2010 | 0,3626 USD |
| 11/03/2010 | 0,3626 USD |
| 11/12/2009 | 0,3626 USD |
| 02/09/2009 | 0,3626 USD |
| 04/06/2009 | 0,3626 USD |
| 04/03/2009 | 0,3626 USD |
| 03/12/2008 | 0,3626 USD |
| 03/09/2008 | 0,3626 USD |
| 04/06/2008 | 0,3626 USD |
| 05/03/2008 | 0,3626 USD |
| 05/12/2007 | 0,3626 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 10/05/1978 | 1,42 | 1,43 | 1,41 | 1,42 | +0,00% | 1,17% | 1.780.762 |
| 09/05/1978 | 1,44 | 1,45 | 1,41 | 1,42 | -1,38% | 2,77% | 3.504.931 |
| 08/05/1978 | 1,46 | 1,46 | 1,42 | 1,44 | -1,37% | 2,27% | 1.844.899 |
| 05/05/1978 | 1,48 | 1,49 | 1,45 | 1,46 | -1,57% | 2,90% | 3.719.981 |
| 04/05/1978 | 1,49 | 1,49 | 1,46 | 1,48 | -2,62% | 1,78% | 5.745.974 |
| 03/05/1978 | 1,51 | 1,54 | 1,51 | 1,52 | +0,44% | 2,19% | 3.120.106 |
| 02/05/1978 | 1,50 | 1,54 | 1,49 | 1,51 | +1,10% | 3,32% | 4.165.171 |
| 01/05/1978 | 1,48 | 1,51 | 1,48 | 1,50 | +1,12% | 2,01% | 5.002.733 |
| 28/04/1978 | 1,47 | 1,48 | 1,46 | 1,48 | +0,91% | 1,36% | 3.746.390 |
| 27/04/1978 | 1,47 | 1,48 | 1,44 | 1,47 | -0,23% | 2,25% | 4.746.182 |
| 26/04/1978 | 1,47 | 1,49 | 1,46 | 1,47 | +0,00% | 2,03% | 5.168.736 |
| 25/04/1978 | 1,46 | 1,49 | 1,46 | 1,47 | +1,60% | 1,81% | 7.466.371 |
| 24/04/1978 | 1,42 | 1,45 | 1,42 | 1,45 | +1,86% | 1,86% | 1.988.266 |
| 21/04/1978 | 1,41 | 1,43 | 1,41 | 1,42 | +0,47% | 0,94% | 3.821.846 |
| 20/04/1978 | 1,41 | 1,44 | 1,41 | 1,41 | +0,23% | 2,11% | 4.746.182 |
| 19/04/1978 | 1,39 | 1,42 | 1,39 | 1,41 | +1,18% | 2,14% | 2.727.734 |
| 18/04/1978 | 1,42 | 1,42 | 1,38 | 1,39 | -2,09% | 2,79% | 2.603.232 |
| 17/04/1978 | 1,42 | 1,44 | 1,42 | 1,42 | +0,71% | 1,40% | 4.478.314 |
| 14/04/1978 | 1,40 | 1,43 | 1,40 | 1,41 | +2,15% | 2,13% | 5.810.112 |
| 13/04/1978 | 1,35 | 1,38 | 1,35 | 1,38 | +2,70% | 2,70% | 3.067.286 |
| 12/04/1978 | 1,34 | 1,35 | 1,33 | 1,35 | +0,75% | 1,73% | 1.377.072 |
| 11/04/1978 | 1,34 | 1,34 | 1,33 | 1,34 | -0,25% | 1,23% | 1.912.810 |
| 10/04/1978 | 1,32 | 1,35 | 1,32 | 1,34 | +1,76% | 2,27% | 1.520.438 |
| 07/04/1978 | 1,31 | 1,33 | 1,30 | 1,32 | +0,76% | 2,28% | 2.637.187 |
| 06/04/1978 | 1,31 | 1,32 | 1,30 | 1,31 | +0,00% | 1,26% | 1.984.493 |
| 05/04/1978 | 1,30 | 1,31 | 1,30 | 1,31 | +1,02% | 1,27% | 1.969.402 |
| 04/04/1978 | 1,29 | 1,30 | 1,29 | 1,30 | +1,04% | 1,03% | 2.542.867 |
| 03/04/1978 | 1,29 | 1,29 | 1,28 | 1,28 | -0,51% | 0,77% | 1.746.806 |
| 31/03/1978 | 1,29 | 1,30 | 1,29 | 1,29 | -0,26% | 0,77% | 1.901.491 |
| 30/03/1978 | 1,29 | 1,30 | 1,28 | 1,29 | +0,00% | 1,28% | 2.195.770 |